Abstract
Hydrophobic alginate derivative was prepared by the modification of alginate with methyl oleate. The synthesized oleate alginate ester (OAE) conjugate was characterized by FTIR and 1HNMR analysis. Results of critical aggregation concentration (CAC) revealed that OAE conjugate had low CAC and was prone to form self-assembled nanoparticles in aqueous medium. Curcumin loaded OAE nanoparticles (Cur-OAE Nps) were developed by a simple sonication method and the physicochemical parameters of the nanoparticles such as zeta potential, size distribution and drug encapsulation were characterized. The results showed that zeta potential of the prepared nanoparticles was -55.4±0.91 mV and the average size was about 200 nm. A significant enhancement in aqueous solubility and stability of curcumin were observed after encapsulation into OAE nanoparticles. With the increase of curcumin concentration, loading efficiency increased but encapsulation efficiency decreased. The in vitro release profile exhibited significant sustained release pattern with initial burst release followed by a slower release over a period of one week. Cytotoxicity assay against MCF-7cells showed that Cur-OAE Nps had slow and continuous cytotoxic effect. Furthermore, in vitro cell uptake study revealed that cell uptake of curcumin from OAE nanoparticles was sustained and both were time and concentration dependent. Therefore, the developed Cur-OAE Nps might be promising candidates for curcumin delivery to cancer cells.
Keywords: Alginate, Curcumin, Cytotoxicity, Cell uptake studies, Methyl-oleate, Nanoparticles, Self - assembled.
Current Drug Delivery
Title:Nanoparticles based on oleate alginate ester as curcumin delivery system
Volume: 12 Issue: 5
Author(s): Mazhar Ali Raja, Chenguang Liu and Zhenhua Huang
Affiliation:
Keywords: Alginate, Curcumin, Cytotoxicity, Cell uptake studies, Methyl-oleate, Nanoparticles, Self - assembled.
Abstract: Hydrophobic alginate derivative was prepared by the modification of alginate with methyl oleate. The synthesized oleate alginate ester (OAE) conjugate was characterized by FTIR and 1HNMR analysis. Results of critical aggregation concentration (CAC) revealed that OAE conjugate had low CAC and was prone to form self-assembled nanoparticles in aqueous medium. Curcumin loaded OAE nanoparticles (Cur-OAE Nps) were developed by a simple sonication method and the physicochemical parameters of the nanoparticles such as zeta potential, size distribution and drug encapsulation were characterized. The results showed that zeta potential of the prepared nanoparticles was -55.4±0.91 mV and the average size was about 200 nm. A significant enhancement in aqueous solubility and stability of curcumin were observed after encapsulation into OAE nanoparticles. With the increase of curcumin concentration, loading efficiency increased but encapsulation efficiency decreased. The in vitro release profile exhibited significant sustained release pattern with initial burst release followed by a slower release over a period of one week. Cytotoxicity assay against MCF-7cells showed that Cur-OAE Nps had slow and continuous cytotoxic effect. Furthermore, in vitro cell uptake study revealed that cell uptake of curcumin from OAE nanoparticles was sustained and both were time and concentration dependent. Therefore, the developed Cur-OAE Nps might be promising candidates for curcumin delivery to cancer cells.
Export Options
About this article
Cite this article as:
Ali Raja Mazhar, Liu Chenguang and Huang Zhenhua, Nanoparticles based on oleate alginate ester as curcumin delivery system , Current Drug Delivery 2015; 12 (5) . https://dx.doi.org/10.2174/1567201812666150511095029
DOI https://dx.doi.org/10.2174/1567201812666150511095029 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer
Combinatorial Chemistry & High Throughput Screening iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design Multimodality Imaging of RNA Interference
Current Medicinal Chemistry The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals
Current Drug Targets The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
Current Medicinal Chemistry Pharmacogenetics of Drug Transporters and Its Impact on the Pharmacotherapy
Current Topics in Medicinal Chemistry Craniofacial Fibrous Dysplasia Involvements of Mccune-Albright Syndrome: A Review with an Additional Case
Current Medical Imaging Radiological Assessment of Giant Cell Tumour of Bone in the Sacrum: From Diagnosis to Treatment Response Evaluation
Current Medical Imaging A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Current Pharmaceutical Biotechnology The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Current Medicinal Chemistry Potentials of Hydrogels in Cancer Therapy
Current Cancer Therapy Reviews The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma
Current Cancer Drug Targets Melanoma Differentiation Associated Gene-7 (mda-7)/ Interleukin-24 (IL-24), mda-7/IL-24: Current Perspectives on a Unique Member of the IL-10 Family of Cytokines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Emerging Therapeutic Approaches Based on Nanotechnology for the Treatment of Diseases Associated with Telomere Dysfunction
Mini-Reviews in Medicinal Chemistry Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets